Thanks to its intellectual assets of 170,000 extracts and 15,000 strains, an enormous potential to be subjected to screening activities, the Foundation strongly believes in the possibility of discovering and developing new drugs and new therapies. For this reason, the Foundation invests heavily in its own research activities, through a team of highly experienced researchers from Pfizer Vicuron.
PROJECTS IN PROGRESS
CELIAC DISEASE
Search for new glutenases of microbial origin for oral therapy ...
NEW ANTIBIOTICS
Two lines of research in collaboration with the Sacco Hospital ...
D-AMINO ACIDS
D-amino acids are involved in main physiological processe...
PROJECTS CONCLUDED
AGROFOOD
The aim of the project was to identify and characterize genes involved in agricultural sector production processes ...
ANTICANCER
Search for new anticancer drugs of natural origin and innovative diagnostic systems for ...
MICROREACTORS
The project aimed to experiment with new technologies to reduce pollution through the use of micro-reactors ...